Both gain-of-function and loss-of-function mutants of unc-104 have been used to study the molecular mechanisms of KIF1A-associated neurological disorder (KAND) and Charcot-Marie-Tooth disease type 2A (CMT2A) [13–15]. Here, KIF1A is linked to Charcot-Marie-Tooth disease type 2A1.